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THE aim of  this study was to determine phenotypic
differences when BCG invades macrophages. Bacilli
prepared  from  the  same  BCG  primary  seed,  but
produced in different culture media, were analysed
with respect to the ability to stimulate macrophages
and  the  susceptibility  to  treatment  with  cytokines
and nitric oxide (NO). Tumour necrosis factor (TNF)
activity was assayed by measuring its cytotoxic activ-
ity on L-929 cells, interleukin-6 (IL-6) and interferon-
g (IFN-g )  were  assayed  by  enzyme-linked  immuno-
sorbent  assay  (ELISA),  whereas  NO  levels  were
detected  by  Griess  colorimetric  reactions  in  the
culture supernatant of macrophages incubated with
IFN-g ,  TNF  or  NO  and  subsequently  exposed  to
either BCG-I or BCG-S. We found that BCG-I and BCG-
S bacilli showed different ability to simulate perito-
neal macrophages. Similar levels of IL-6 were detec-
ted in stimulated macrophages with lysate from two
BCG  samples.  The  highest  levels  of  TNF  and  IFN-g
were  observed  in  macrophages  treated  with  BCG-S
and  BCG-I,  respectively.  The  highest  levels  of  NO
were  observed  in  cultures  stimulated  for  48 h  with
BCG-S. We also found a different susceptibility of the
bacilli  to  exogenous  treatment  with  IFN-g and  TNF
which  were  capable  of  killing  60  and 70%  of  both
bacilli, whereas NO was capable of killing about 98
and  47%  of  BCG-I  and  BCG-S,  respectively.  The
amount of bacilli proportionally decreased with IFN-
g and  TNF,  suggesting  a  cytokine-related  cytotoxic
effect. Moreover, NO also decreased the viable num-
ber of  bacilli.  Interestingly,  NO  levels of  peritoneal
macrophages were significantly increased after cyto-
kine treatment.  This indicates that the treatment of
macrophages  with  cytokines  markedly  reduced
bacilli number and presented effects on NO produc-
tion.  The  results  obtained  here  emphasize  the
importance of adequate stimulation for guaranteeing
efficient killing of bacilli. In this particular case, the
IFN-g and  TNF  were  involved  in  the  activation  of
macrophage bactericidal activity.
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Introduction
Mycobacteria are intracellular pathogens which prefer-
entially  reside  in  resident  macrophages,  whereas
activated macrophages are presumed to eliminate the
bacteria effectively. Mycobacterium tuberculosis, the
causative agent of tuberculosis, enters the macrophage
via binding to several distinct cell surface molecules.
Following phagocytosis, sustained intracellular bacte-
rial growth depends on the ability to avoid destruction
by macrophage-mediated host defences such as lyso-
somal  enzymes,  reactive  oxygen,  reactive  nitrogen
intermediates and cytokines. Resistance to tuberculosis
crucially depends on specific T cells which activate
intracellular killing of the infectious agent by macro-
phages.1CD4  T cells comprise two functionally distinct
helper  subsets  according to  their  cytokine  profiles,
namely, Th1 and Th2 cells.2–4 Predominance of Th1 or
Th2 cell responses has an important influence on the
outcome of infection with intracellular pathogens.5The
development of the  Th cell type is influenced by several
cytokines, such as interleukin-4 (IL-4) and interferon-g
(IFN-g),2 which  are  produced  at  the  onset  of  an
immune response and are thought to be decisive for
pathological  or  physiological  consequences.6 The
release of cytokines by macrophages has shown that
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contribute  to  the  pathophysiology  of  a  range  of
diseases.2,6,7 Previous  studies  have  shown  that  the
control of  mycobacterial infections depends  on the
cytokine-mediated activation of mononuclear phago-
cytes  to  inhibit  the  growth  of  intracellular  myco-
bacteria.  Recent  studies  demonstrated  that  tumour
necrosis  factor-a (TNF-a)  acts  as  an  endogenous
cofactor  in  the  induction  of  mycobacterial  growth
inhibition.8 Murine peritoneal macrophages activated
with  IFN-g produce  large  quantities  of  nitric  oxide
(NO) and are efficient in killing certain intracellular
pathogens.9 This study shows the susceptibility and/
or  resistance  of  two  kinds  of  BCG  bacilli  which
were  cultivated  in  two  distinct  medium:  Instituto
Viscondessa  de  Moraes  medium  (IVM)  and  Sauton
medium,  here  referred  to  as  BCG-I  and  BCG-S,
respectively. The  resistance  may  reflect  in  part  the
ability  of  these  organisms  to  resist  the  enhanced
bacteriostatic  and  bactericidal  properties  acquired
by  host  macrophages  as  a  result  of  these  myco-
bacterial infections.
Materials and methods
Chemicals, reagents and buffers
RPMI-1640 medium, actinomycin D, orthophenyldia-
mine  (OPD),  sodium  nitrate  (NO)  were  purchased
from  Sigma  (St.  Louis,  MO,  USA),  fetal  calf  serum
(FCS)  was  purchased  from  Cutilab,  Campinas,SP-
Brazil, murine anti-IL-6 (clones: MP5–20F3 and MP5–
32.C.11), rIL-6, anti-IFN-g (clones XGM1.2 and AN18),
rIFN-g were purchased from PharMingen (Toreyana,
San  Diego,  USA)  and  rTNF ,  p-nitrophenylphosphate
(pNPP) were purchased from Boehringer Mannheim
(Germany).
BCG bacilli
The BCG used in this study was Moreau, Copenha-
gen strain, which was stored in a freeze-dried state
at –20°C and called BCG primary lots. The second-
ary  seed  lots  were  derived  from  the  primary  seed
lots and cultivated by two passages on Sauton potato
medium  before  being  transferred  to  the  liquid
media. They  were  prepared  in  batches  of  samples,
using  IVM  medium  for  the  expansion  of  BCG-I,
while  BCG-S  was  expanded  in  liquid  Sauton
medium.10 The veils grown on the surface of liquid
IVM and Sauton medium for 11 and 7 days, respec-
tively, were used. The bacillary  mass was separated
from  the  culture  medium,  then  resuspended  in
Sauton  medium  and  homogenized  by  ball-milling.
The bacillary  mass obtained for the BCG-S prepara-
tion was separated from  the culture  medium,  then
homogenized  by  ball-milling  and  resuspended  in
sodium glutamate as a protective excipient for freeze-
drying. The optical density was determined at 390nm
and 400nm for BCG-I and BCG-S, respectively.
Lysates of BCG bacilli
Lysates of BCG were obtained from bacilli BCG-I and
BCG-S.11 In brief: 107 colony-forming units (cfu) were
incubated in 1ml of saline solution at 60°C for 60min
and sonication was performed for 15min at 100W to
promote cell lysis. The cell lysate thus obtained was
stored at –20°C until use. The mixtures obtained were
used for macrophage stimulation.
Stimulation of mouse peritoneal macrophages
BALB/c mice (20–22g) were obtained from Biot´ erio
(Instituto  Butantan,  SP,  Brazil).  All  animals  were
maintained under strict ethical conditions according
to international recommendations.12 Groups of mice
were  sacrificed  and  their  cells  were  harvested  by
peritoneal lavage.13The cells were seeded in 24-well
microtitre plates at a concentration of 1 ´ 106cells/ml
and  cultured  in  RPMI-1640  medium  supplemented
with  10%  FCS. After  incubation  at  37°C  for  2h  in
humidified  5%  CO2,  the  plates  were  then  washed
twice  with  RPMI-1640  medium  to  remove  non-
adherent cells and the adherent cells were referred to
as macrophages. These cells were exposed to different
concentrations of lysate of BCG-I or BCG-S in RPMI–
1640 containing 10% FCS. After incubation at 37°C for
various intervals of time in a humidified atmosphere of
5% CO2, the supernatants were collected and stored at
–20°C until assayed for the presence of cytokines, NO
and acid phosphatase activity.
Cytokine determination
The levels of cytokines IL-6 and IFN-g in the culture
supernatants  were  assayed  by  two-site  sandwich
enzyme-linked  immunosorbent  assay  (ELISA).14
Briefly,  ELISA  plates  were  coated  with  100ml
(1mg/ml)  of  the  monoclonal  antibodies anti-IL-6 or
anti-IFNg in 0.1M sodium carbonate buffer, pH 8.2,
and incubated for 6h at room temperature. The wells
were  then  washed  with  0.1%  phosphate-buffered
saline  (PBS)/Tween  20  and blocked  with  100ml  of
FCS in  10%  PBS for 2h at room temperature. After
washing, duplicate supernatant macrophage culture
samples of 50ml were added to each well. After 18h
of  incubation  at  4°C  the  wells  were  washed  and
incubated with 100ml (2mg/ml) of the biotinylated
monoclonal antibodies anti-IL-6 or anti-IFN-g as sec-
ond antibodies for 45min at room temperature. After
a  final  wash,  the  reaction  was  developed  by  the
addition of OPD to each well. Optical densities were
measured  at  405nm  in  a  microplate  reader.  The
cytokine  content  of  each  sample  was  read  from  a
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recombinant cytokine and expressed in  ng/ml. The
minimum  levels of  each cytokine detectable in  the
conditions of the assays were 0.78 and 3.9ng/ml for
IL-6 and IFN-g, respectively.
To measure the cytotoxicity of TNF present in the
supernatants from the macrophages, a standard assay
with L-929 cells, a fibroblast continuous cell line, was
used as described previously.15The percentage cytox-
icity  was  calculated  as  follows:  (Acontrol – Asample/
Acontrol) ´ 100 and the titres were calculated as the
reciprocal of the dilution of the sample in which 50%
of the cells in the monolayers were lysed. TNF activity
was  expressed  in  ng/ml  estimated  from  the  ratio
between a 50% cytotoxic dose of the test and that of
standard recombinant mouse TNF.
NO determination
The levels of NO in supernatants from macrophages
treated with BCG-I or BCG-S bacilli were assayed by
adding 50ml of freshly prepared Griess reagent16 to
50ml of the sample in 96-well plates and reading the
absorbance  at  540nm  10min  later  by  comparison
with  the  absorbance  curves  of  serial  dilutions  of
sodium  nitrate  in  complete  culture  medium.  The
minimum  level  of  NO  detectable  under  the  assay
conditions was 1nmol.
Macrophage activation (acid phosphatase
activity)
The  acid  phosphatase activity  of  peritoneal  macro-
phages  from  mice  was  determined  as  described
previously.17 In  brief:  macrophages  obtained  and
stimulated as described above were placed in a test
tube  and  allowed  to  stand  at  34°C  for  20min  to
permit macrophage adherence to the glass surface.
The tubes were washed three times with PBS, 2ml of
water was added, and sonication was performed for
30s at 100W to promote cell lysis. To the cell lysate
thus obtained 1.5ml 0.3M citrate buffer, pH 4.9, and
0.2ml 0.04M pNPP substrate were added. The mix-
ture was incubated at 37°C for 1h, and 0.5ml 1M Tris,
pH  8.5,  containing  0.4M  K2PO4 was  added.  The
absorbance was then read at 420nm using a Pharma-
cia spectrophotometer. Protein determination in the
cell lysate was carried out using the method of Lowry
et al.18 Enzyme activity was defined as the units of
optical density of nitrophenol released per milligram
of protein per hour.
cfu assay
Bacterial  loads  in  the  peritoneal  macrophages trea-
ted  with  BCG  bacilli  were  evaluated  by  plating
10-fold serial dilutions of macrophage homogenates
in PBS on to L¨ owenstein-Jensen tubes and incubating
at 37°C for 28 days. The bacterial colonies of each
culture (six replicate samples) were counted and the
mean calculated.
Statistical analyses
Data are expressed as the mean ± standard deviations
(SD). Statistical analyses were performed by Student’s
t-test and the level of significance was set at p < 0.05.
Results
Effect of BCG bacilli on macrophage activation
To compare macrophage activation, mice were sacri-
ficed and the macrophages which had been stimulated
with different amounts of viable and lysate BCG were
collected by peritoneal lavage. The effects of lysate
BCG bacilli upon macrophage stimulation were deter-
mined by measuring acid phosphatase activity. Both
viable  and  lysate  BCG  were  capable  of  increasing
macrophage activation. As shown in Fig. 1A, similar
levels  of  activation  for  all  groups  of  macrophages
treated with viable and lysate BCG were observed 24h
after this treatment. For all groups of mice treated with
viable and lysate BCG this level increased with increase
in stimulation dose until a plateau was attained.
To analyse the lysate BCG bacilli interference with
macrophage activation, cells were obtained from mice
and stimulated in vitro with different amounts of lysate
BCG.  Figure  1B  shows  that  the  lysate  BCG  bacilli
showed similar  ability  to stimulate  macrophages in
vitro.  Macrophage  activation  was  increased  with
increase in dose of lysate BCG bacilli. With doses of 10
and  50mg/ml,  low  stimulation  was  observed  in  all
groups of macrophages treated with both lysates. In
contrast, for groups  treated with  higher doses, the
stimulation started to appear at 100mg/ml increasing
thereafter  until  a  plateau  was  attained  at
500–1000mg/ml.  Although  an  increased  level  of
stimulation was observed in all groups, this increase
was no different between BCG-I and BCG-S (Fig. 1B).
To determine the kinetics of the effects of lysate
BCG  bacilli,  cells  were  obtained  from  mice  and
stimulated in vitro with 100mg/ml of lysate BCG (Fig.
1C).  The  highest  macrophage  activation  by  BCG-I
occurred 24h post-treatment. In contrast, the highest
activation  by  BCG-S  occurred  around  48h  post-
treatment. The levels of activation were almost twice
as high in macrophages stimulated in vitro with lysate
BCG-S  when  compared  with  those  obtained  for
macrophages treated with lysate O-BCG (Fig. 1C).
Effect of lysate BCG bacilli in in vitro activation
To  compare  cytokine  production,  groups  of  mice
were sacrificed and their macrophages, which were
collected  by  peritoneal  lavage,  were  stimulated  in
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vitro with 100mg/ml lysate BCG bacilli (Fig. 2). The
levels of IFN-g increased until 72h in all macrophage
groups stimulated in vitro with both lysates (Fig. 2A).
The  levels  of  IFN-g in  groups  of  macrophages
stimulated  in  vitro with  lysate  BCG-I  were  higher
when  compared  with  those  obtained  in  cultures
stimulated with lysate BCG-S (p > 0.001). Figure 2B
shows that the levels of TNF started to appear after
24h in all cultures, decreasing thereafter. The highest
levels of TNF were observed in macrophages stimu-
lated in vitro for 48hh for both lysates. The levels of
TNF  in  groups  of  macrophages stimulated  in  vitro
with  lysate  BCG-I  were  significantly  lower  when
compared with those obtained in cultures stimulated
with BCG-S (p > 0.01). As shown in Fig. 2C, similar
levels  were detected in  macrophages stimulated in
vitro with  lysate  from  both  bacilli. The  maximum
production of IL-6 was detected in cultures stimulated
for 24h.
To  determine  NO  production,  groups  of  mice
were sacrificed and macrophages collected by peri-
toneal  lavage  were  stimulated  in  vitro with
100mg/ml of lysate BCG bacilli (Fig. 3). The levels of
NO increased until 48 and 72h for BCG-I and BCG-S,
respectively. The levels of NO in macrophages stimu-
lated  in  vitro with  lysate  BCG-S  were  significantly
higher  than  those  obtained  in  cultures  stimulated
with BCG-I (p >  0.001).
Growth inhibition of BCG bacilli in
macrophages
To  evaluate  the  growth  of  viable  BCG  bacilli  in
macrophages,  groups  of  mice  were  sacrificed  and
V.L. Petricevich et al.
264 Mediators of Inflammation · Vol 9 · 2000
FIG. 1. Macrophage activation. (A) Groups of BALB/c mice were sacrificed and their peritoneal macrophages collected and
stimulated in vitro with 100mg of viable or lysate BCG bacilli for 48h and activation was determined by measurement of acid
phosphatase activity. (B) Peritoneal macrophages from mice were obtained and stimulated in vitro for 48h with different
amounts of BCG lists. (C) Peritoneal macrophages from mice were obtained and stimulated in vitro for different times with
100mg/ml of BCG lysates. Each point represents the values of samples from five experiments ± standard deviation in different
groups of five mice.g
m
macrophages collected by peritoneal lavage. The cells
were infected in vitro with 1.5 ´ 106 cfu of viable
BCG bacilli for 24, 48, 72, 96 and 120h. Afterwards
macrophage  homogenates  were  obtained  to  deter-
mine the viable bacilli number. The number of bacilli
in  macrophages  was  determined  by  plating  the
suspension on L¨ owenstein-Jensen tubes, and counting
the cfu 28 days later. The number of viable BCG-I and
BCG-S recovered from macrophages decreased with
increasing culture time in all groups (Fig. 4).
Susceptibility of BCG to cytokines
To determine the susceptibility of BCG to cytokines,
macrophages from mice were collected and separated
into three groups. In the first group, referred to as
‘before’, the macrophages were treated with 125mg
of recombinant cytokines for 24h and infected with
1.5 ´ 106 cfu of BCG-I or BCG-S. In the second group,
‘during’, the macrophages were treated with the same
concentration of recombinant cytokines and infected
with same dose of  BCG bacilli. In the third group,
‘after’, the macrophages were infected with 1.5 ´ 106
cfu  of  BCG  bacilli  for  24h  and  then  treated  with
125mg of recombinant cytokines. As shown in Table
1, the lowest viable bacilli number was observed in
macrophages from the ‘before’ group. In contrast, the
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FIG. 2. Cytokine released by peritoneal macrophages from
BALB/c  mice.  Mice  were  sacrificed  and  their  peritoneal
macrophages were collected. Peritoneal macrophages were
stimulated in vitro with 100mg of BCG lysates and at different
time  intervals  the  supernatants  were  collected.  Tumour
necrosis  factor  activity  was  assayed  by  measuring  its
cytotoxic activity on L-929 cells, whereas interleukin-6 and
interferon-g were assayed by enzyme-linked immunosorbent
assay using monoclonal antibodies as the probe. Each point
represents the values of samples from five experiments ±
standard deviation in different groups of five mice.
FIG. 3. Nitric oxide (NO) production. Mice were sacrificed and
their  peritoneal  macrophages  were  collected.  Peritoneal
macrophages were stimulated in vitro as described above.
NO  levels  were  detected  by  Griess  colorimetric  reaction.
Each  point  represents  the  values  of  samples  from  five
experiments ± standard deviation in different groups of five
mice.
FIG.  4.  Growth  inhibition  of  BCG  bacilli  in  peritoneal
macrophages. Groups of five mice were sacrificed and their
peritoneal macrophages collected and infected with 1.5 ´ 106
colony-forming units of BCG-I or BCG-S. At different times
the number of intracellular bacilli was assessed as described
in Materials and Methods. Each point represents the values
of  samples from  five experiments ± standard deviation in
different groups of five mice.





highest number of viable BCG was observed for the
groups ‘during’ and ‘after’ (Table 1).
After  establishment,  an  optimal  time  stimulation
resulted  in  the  lowest  number  of  viable  BCG,  this
implies that, given a certain amount of recombinant
cytokine available for infection, there should exist an
optimal concentration and consequently less bacilli.
Macrophages were obtained and treated in vitro with
different  concentrations  of  recombinant  cytokines
alone  or  combined  for  24h,  followed  by  BCG
infection. The rate of growth inhibition was assessed
by lysing the macrophages 48h after this treatment
and counting the number of cfu in L¨ owenstein-Jensen
tubes 28 days later. Figure 5A shows that at 125mg of
IFN-g the macrophages were capable of killing around
70% of both bacilli. Figure 5B shows that 125mg of
TNF was capable of killing about 60 and 54% of BCG-I
and  BCG-S,  respectively.  Figure  5C shows that TNF
plus IFN-g was capable of killing about 62% of both
BCG bacilli.
In order to verify if the exogenous cytokine showed
a  cytotoxic  effect  on  BCG  bacilli,  NO  levels  were
determined (Fig. 6). The levels of NO increased with
increasing cytokine dose for all groups. With a dose of
125mg/ml of IFN-g, TNF alone or combined, the levels
of NO were highest when compared with the levels
obtained in untreated macrophages.
Susceptibility of BCG to NO
To determine if NO plays a role in the susceptibility of
bacilli  in  the  absence  of  the  other  products  of
activated effector cells, the level of mortality of bacilli
in the presence of NO was examined. 1.5 ´ 106 cfu of
BCG-I or BCG-S were exposed at different concentra-
tions of  NO for 24h. The lowest number  of  viable
bacilli were observed when macrophages were trea-
ted with NO (Fig. 7). Doses of 1.9 and 3.75mmol of
NO were capable of killing around 20% of both bacilli.
In  contrast,  when  macrophages  were  treated  with
7.5mmol of NO, the number of killed bacilli was 47
and  43%  for  BCG-I  and  BCG-S,  respectively.  The
number  of  killed  BCG-S  bacilli  observed in  macro-
phage groups treated with 15mmol of NO was around
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FIG. 5. Growth inhibition and susceptibility of BCG bacilli.
Groups  of  five  mice  were  sacrificed  and  their  peritoneal
macrophages  were  collected.  Macrophages  were  treated
with different concentrations of interferon-g (IFN-g), tumour
necrosis factor (TNF) or IFN-g + TNF for 24h and infected
with 1.5 ´ 10
6 colony-forming units of viable BCG bacilli. The
number of intracellular bacilli was assessed as described in
Materials and Methods. Each point represents the values of
samples  from  five  experiments  ±  standard  deviation  in
different groups of five mice.
FIG. 6. Cytotoxic effect of cytokines. Groups of five mice were
sacrificed and their peritoneal macrophages were collected.
Macrophages were treated with different concentrations of
interferon-g (IFN-g), tumour necrosis factor (TNF) or IFN-g +
TNF for 24h and infected with 1.5 ´ 10
6 colony-forming units
of viable BCG bacilli. Nitric oxide (NO) levels were assayed
by the Griess colorimetric reactions. Each point represents
the  values  of  samples  from  five  experiments ±  standard
deviation in different groups of five mice.







IFN-g 2450 2300 4450 4580 5900 5000
TNF 3230 3450 6630 6600 7700 6820
IFN-g + TNF 3078 2850 5278 6455 6680 6890
IFN, interferon; TNF, tumour necrosis factor.m
47%,  while  the  number  of  killed  BCG-I  bacilli
observed in macrophages treated with 15mmol of NO
was 98% (Fig. 7).
Discussion
Historically, researchers have assumed that activated
macrophages can kill M. tuberculosis. However, this
assumption has been difficult to prove unequivocally
in  vitro,  especially  with  human  monocytes  and
macrophages. Human monocytes cultured for 3 days
were measurably better at suppressing the growth of
virulent  M.  tuberculosis than  were  either  fresh
monocytes or those cultured for 7 days.19 Following
treatment with cytokines such as IFN-gand  TNF, human
monocytes  can  be  activated  showing  an  intense
microbicidal.20 However,  a more recent report  sug-
gested  that  this  apparent  killing  of  M.  tuberculosis
could be an artefact of the experiment and that this
cytokine treatment regimen  actually  renders macro-
phages  more  sensitive  to  the  toxic  effects  of  the
mycobacteria.21
Mycobacteria  are  intracellular  pathogens  which
survive  and  grow  in  host  macrophages,  whereas
activated macrophages are presumed to eliminate the
bacteria  effectively.22 Mycobacterium  tuberculosis
bacilli  enter the  macrophage via binding  to  several
distinct cell surface molecules. Following phagocyto-
sis, sustained intracellular bacterial growth depends on
the  ability  to  avoid  destruction  by  macrophage-
mediated host defences such as lysosomal enzymes,
reactive oxygen and reactive nitrogen intermediates.23
Should it occur, the killing of ingested M. tubercu-
losis would  most  likely  take  place  within  macro-
phage  phagolysosomes.  Toxic  constituents  found
within  this  acidic  vesicle  include  lysosomal  hydro-
lases,  reactive  oxygen  intermediates  such  as  H2O2
and O–
2,and reactive nitrogen intermediates such as
NO and NO–
2. The resistance of several strains of M.
tuberculosis to  reactive  nitrogen  intermediates  in
vitro,  generated  at  an  acidic  pH,  was  found  to
correlate significantly with the virulence of the strain
tested.24 Reactive  nitrogen  intermediate  production
by  murine  macrophages  is  an  important  effector
mechanism against a variety of pathogens.25 In mac-
rophages,  NO  and  other  reactive  nitrogen  inter-
mediates  are  derived  from  L-arginine  via  an  enzy-
matic  pathway  controlled  by  an  inducible  NO
synthase  (iNOS).26 Cytokines  are  powerful  mod-
ulators  of  murine  macrophage  reactive  nitrogen
intermediate  synthesis.  While  TNF  and  IFN-g are
potent  activators  of  iNOS,  IL-4  and  IL-10  suppress
it.27–29
NO is known to be involved in multiple biologically
important reactions, including  those with transition
metal  ions,  thiols,  and  redox  forms  of  oxygen.30
Infections  with  pathogenic  mycobacteria  are  asso-
ciated with the development of a persistent decrease
in  the  number  of  bacilli.31 This study  describes  an
experimental model designed to test the hypothesis
that this persistence may reflect in part the ability of
these BCG bacilli to resist the enhanced bacteristatic
and bactericidal properties acquired by host macro-
phages as a result of these mycobacterial infections.
To examine this possibility, macrophages from mice
were inoculated with viable or lysate BCG bacilli and
the  macrophage  activation  was  compared.  Both
bacilli forms were capable of activating macrophages.
Thus, the effects of lysate BCG bacilli upon macro-
phage activation were observed. Comparative analy-
ses of these two types of lysate BCG in macrophages
from  mice  demonstrated  that  a  difference  exists
between these bacilli.
Resident  peritoneal  macrophages  released  a  sig-
nificant amount of cytokines and NO in response to
lysate BCG bacilli. The highest levels of IFN-g were
observed  in  macrophages  from  mice  treated  with
BCG-I. The highest levels of TNF were observed for
BCG-S groups and similar levels of IL-6 were observed
for  both  groups.  Lysate  BCG-I  and  BCG-S  were
compared for the ability to induce NO production in
peritoneal  macrophages.  Cytokines  participate  in
many physiological processes including immune and
inflammatory responses. These effector molecules are
produced transiently and locally control the amplitude
and duration of the response. A variety of experiments
showed that excessive or insufficient production may
significantly  contribute to the pathophysiology of a
range of diseases. Particularly, cytokines released by
CD4+ T cells at the onset of an immune response are
thought  to  be  decisive  for  pathological  or  physio-
logical consequences.6 In spite of the physiological
and  pathological  importance  of  TNF,  the  cellular
factors  that  govern  its  release  by  macrophages  are
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FIG. 7. Susceptibility of BCG bacilli to nitric oxide (NO): 1.5 ´
10
6 colony-forming units of BCG-I or BCG-S were exposed to
different amounts of NO for 24h. The number of viable BCG-I
or  BCG-S  was  assessed  as  described  in  Materials  and
Methods. Each point represents the values of samples from
five experiments ± standard deviation in different groups of
five mice.poorly understood, in comparison with other secretor
products.7 The  determination  for  macrophage  anti-
mycobacterial activity against M. bovis identified the
cytokines  involved  in  regulating  the  NO-mediated
killing of this mycobacterium.32 Growth inhibition of
M. bovis by IFN-g stimulated macrophage regulation
by endogenous TNF and by IL-10.32
In this study, we compared the abilities of IFN-g,
TNF-a to activate syngeneic murine peritoneal macro-
phages to inhibit the growth of intracellular BCG in
vitro. IFN-g and TNF-a could activate anti-mycobacter-
ial defence only when added to macrophage cultures
after their infection with BCG.
This study  also investigated  the cytotoxic effects
of IFN-g and TNF secreted by macrophages, and the
role of NO produced by peritoneal macrophages in
cytotoxic  actions  of  cytokines.  Thus,  peritoneal
macrophages were cultured  in medium supplemen-
ted  with  IFN-g and TNF-a,  alone  or  with  various
combinations  of  these  cytokines.  The  number  of
viable  bacilli  was  assessed  by  lysing  the  macro-
phages  at  48h  after  treatment  and  counting  the
number  of  cfus.  Similarly,  the  NO  production,  as
measured by nitrite, by macrophages, obtained from
mice,  in  response  to  cytokine  was  assessed. There
was a significant reduction in the bacilli number by
both  peritoneal  macrophages  collected  after  cyto-
kine treatment. The production of NO by peritoneal
macrophages was significantly  increased after  cyto-
kine treatment. These results suggest that the treat-
ment  of  infected  macrophages  with  recombinant
IFN-g and TNF alone markedly reduced the number
of viable BCG and presented dose-dependent effects
on  NO  production. The  combination  of  IFN-g and
TNF also  reduced the number  of  viable  bacilli  and
caused  a  greater  increase  in  NO production.  IFN-g
and TNF  seem  to  be  important  cytokines  for  the
activation  of  mycobacterial  mechanisms  in  murine
macrophages. The activation of antibacterial effector
functions in macrophages by TH1 cell-derived IFN-g
is  central  to  protection.  In  contrast, TH2  cells  are
only  marginally  involved.33 Murine  peritoneal  mac-
rophages  activated with  IFN-g produce  large  quan-
tities  of  NO  and  are  efficient  in  killing  certain
intracellular pathogens.34
While IFN-g is involved in the activation of mac-
rophage  bactericidal  activity,  other  cytokines  can
have antagonistic effects. IL-10, initially described as
a cytokine synthesis inhibitory factor, has important
regulatory  effects  on  immune  and  inflammatory
responses.35 The suppressive effects of IL-10 on the
host response are predominantly mediated by  mac-
rophages.  IL-10  inhibits  the  production  of  reactive
oxygen  and  reactive  nitrogen  intermediates  when
macrophages are  activated by  IFN-g.36,37 IL-10  also
inhibits TNF-a and IL-12 production by macrophages
and their stimulatory effect on IFN-g production by
natural killer cells.38,39
This study also showed the susceptibility  of BCG
bacilli by exposure to NO. The in vitro resistance of
bacilli to NO, generated at 15mmol/ml, was found to
have a significant (p < 0.05) reduction in the number of
viable BCG-I bacilli. Although increased production of
NO is responsible for heightened microbicidal activity,
in some cases a small number of micro-organisms can
persist, leading to a subpatent infection which induce a
chronic sequel40,41 and even the complete elimination
of  intracellular  micro-organisms.41 Various  micro-
organisms  whose  development  is  inhibited  by  NO
include  fungi,  bacteria,  protozoa,  helminthes  and
viruses.41 Recent studies with a number of microbial
pathogens have established the critical role of NO and
other reactive nitrogen intermediates in the microbial
activity  of  cytokine  stimulated  murine
macrophages.32,40,41
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